Of the remaining 20 cases of ESCC, 45% (9/20) and 35% (7/20) expressed higher VEGFR1 and VEGFR2, respectively, in the cytoplasm of cancer cells compared with cancer-adjacent normal esophageal epithelium (Figure 7A–7B). This evidence concerns the gene FLT1 and esophageal squamous cell carcinoma.